Capps Kathleen S.

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Capps Kathleen S.'s trades of Enanta Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-05 2025-12-05 S Sale
77,231 -44.4%
76.65
US$3,301,424
77,231 -44.4% 76.65 US$3,301,424
2025-12-03 2025-12-02 S Sale
34,538 +12.9%
107.35
US$929,884
34,538 +12.9% 107.35 US$929,884